Compare IDEXX Laboratories, Inc. (IDXX) vs Lowe`s Companies Inc (LOW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Lowe`s Companies Inc — how do they compare? IDEXX Laboratories, Inc. trades at $519.17 (market cap $40.43B), while Lowe`s Companies Inc trades at $184.67 (market cap $105.96B). The key difference: Lowe`s Companies Inc is far larger — about 2.6× IDEXX Laboratories, Inc.'s market cap, and Lowe`s Companies Inc pays a 2.65% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and Lowe`s Companies Inc for 98 Days on average.
| IDXX | LOW | |
|---|---|---|
Market Cap | $40.43B | $105.96B |
Volume | 692,164 | 4,039,547 |
Sector | Health | Consumer Cyclical |
52-Week High | $766.68 | $287.39 |
52-Week Low | $504.70 | $179.50 |
Typical Hold Time | 46 Days | 98 Days |
Enterprise Value | $41.32B | $144.81B |
Dividend Yield | — | 2.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $517.47, up 2.13% with strong earnings momentum after beating Q2 2026 estimates. The stock shows bearish technical signals but maintains robust fundamentals with 25.03% net margins and 74.21% ROE. Recent acquisitions like CoVetAI and expanded diagnostic platforms highlight growth initiatives, while analyst consensus remains bullish with a $665 price target representing 28.5% upside potential.
The outlook remains positive given consistent earnings beats and expanding veterinary diagnostics market share. Key risks include FX headwinds, weaker U.S. vet visits, and premium valuations at 36x P/E. Institutional ownership trends show mixed activity with recent insider selling, but long-term growth drivers in pet healthcare innovation support the bullish analyst stance.
Lowe's (LOW) trades at $181.54, down 1.17% on the day, with a bearish technical signal and recent price weakness amid a slowing home improvement market. The company has beaten earnings estimates for the last three quarters, with a P/E of 15.96 and net income margin of 7.35%. Recent news highlights drone delivery tests with DoorDash and Alphabet, while cash flow improved in 2025 but is projected to decline in 2026.
The stock offers value with a consensus price target of $244.09, implying 34% upside, supported by a 60.79% buy rating from analysts. Risks include high debt levels, competitive pressure from Home Depot, and sensitivity to housing market trends. The current technical setup suggests near-term support at $179, with potential for a rebound if fundamentals hold.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Lowe`s Companies Inc
Lowe's is the second-largest home improvement retailer in the world, operating 1,969 stores and servicing around 230 dealer-owned stores throughout the United States and Canada. The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two thirds of products sold. Lowe's targets retail do-it-yourself (around 75% of sales) and do-it-for-me customers as well as commercial and professional business clients (around 25% of sales). We estimate Lowe's captures a low-double-digit share of the domestic home improvement market, based on U.S. Census data and management's estimates for market size.
Read more on LOW →
